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Abstract
We report the characterisation of 27 cardiovascular-related traits in 23 inbred mouse strains. Mice were phenotyped either
in response to chronic administration of a single dose of the b-adrenergic receptor blocker atenolol or under a low and a
high dose of the b-agonist isoproterenol and compared to baseline condition. The robustness of our data is supported by
high trait heritabilities (typically H
2.0.7) and significant correlations of trait values measured in baseline condition with
independent multistrain datasets of the Mouse Phenome Database. We then focused on the drug-, dose-, and strain-specific
responses to b-stimulation and b-blockade of a selection of traits including heart rate, systolic blood pressure, cardiac
weight indices, ECG parameters and body weight. Because of the wealth of data accumulated, we applied integrative
analyses such as comprehensive bi-clustering to investigate the structure of the response across the different phenotypes,
strains and experimental conditions. Information extracted from these analyses is discussed in terms of novelty and
biological implications. For example, we observe that traits related to ventricular weight in most strains respond only to the
high dose of isoproterenol, while heart rate and atrial weight are already affected by the low dose. Finally, we observe little
concordance between strain similarity based on the phenotypes and genotypic relatedness computed from genomic SNP
profiles. This indicates that cardiovascular phenotypes are unlikely to segregate according to global phylogeny, but rather
be governed by smaller, local differences in the genetic architecture of the various strains.
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Introduction
The b-adrenergic system controls cardiac contractility and
excitability, heart rate and vascular tone. Pharmacological
targeting of b-adrenergic receptors is a well documented first-line
therapeutic approach for the management of cardiac arrhythmias,
cardio-protection after myocardial infarction, and hypertension
[1,2], while b-agonists are administered in cases of bradycardia,
heart block or asthma [3,4]. A major concern in clinical practice is
the marked variability of human responses to such treatments,
often leading to unwanted side-effects or showing at best little relief
[5,6].
The purpose of this study is to explore inter-individual variance
of cardiovascular-related traits induced by sustained pharmaco-
logical perturbations of the b-adrenergic system, using inbred
mouse strains as a model. Atenolol (ate) and isoproterenol (iso) were
chosen for their antagonist effects on b-adrenergic receptors. Ate is
a b-blocker with strong cardio-selectivity for b1-adrenoreceptors.
It is widely prescribed to patients with hypertension, coronary
heart disease, and arrhythmias. In contrast, iso is a classical b-
adrenergic agonist that induces positive cardiac inotropy and
chronotropy. It is administered acutely in cases of bradycardia,
heart block or pulmonary emergencies. In both humans and mice,
ate is mainly eliminated unchanged by the kidneys and the faeces
[7,8], while iso is metabolised within minutes post-administration
into inactive metabolites by the liver catechol-O-methyltransferase
(COMT) [9].
In humans, only about half of hypertensive individuals respond
to ate by a significant reduction of systolic blood pressure [10],
whereas acute delivery of iso may induce differential vasodilatory
effects in healthy subjects [11]. In rodents and other mammals,
sustained activation of the b-adrenergic system by chronic
administration of iso is a classical and well characterised model
of left ventricular hypertrophy (LVH) independent of blood
pressure [12]. LVH is a major risk factor for ventricular
dysfunction and heart failure. In its pathological manifestations,
it is characterised by increased left ventricular mass and wall
thickness, elevated cross-sectional area and dimensions of
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myocardial fibrosis. LVH is further associated with the reactiva-
tion of a foetal transcription program as indicated by up-regulation
of cardiac genes otherwise expressed in myocardium only during
embryonic development [12]. Recent experimental data suggest
that, in mice, iso-induced LVH is modulated by strain-specific
factors. In particular, extensive phenotypic characterisation
revealed that the strain A/J developed greater morphological
changes than C57BL/6J when exposed to five consecutive daily
injections of 100 mg iso per kg body weight [13]. Similarly,
evidence obtained in FVB and C57BL6/SV129 mice challenged
with single injections of 1 mg iso indicates that strain-specific
genetic variants are also likely to modulate the chronotropic action
of iso on heart rate [14].
Here, we report the characterisation of heart rate (HR), systolic
blood pressure (SBP), electrocardiograms (ECG) and cardiac
weight indices in age-matched males of 23 inbred mouse strains.
Rigorous experimental standards were applied so as to minimise
the impact of non-inherited factors on trait values and drug
responses. In particular, physiological consequences of b-adrener-
gic perturbations were tested independently of pathological
influences, measurements were repeated in an average of ten
individuals per strain and per drug condition, and sensitive
phenotypes such as HR and SBP were monitored across three
consecutive days in each mouse, following a training period of one
week. These traits were recorded either in baseline condition (ctr)
or in response to sustained administration of iso at 1 (iso1)o r1 0
(iso10) mg/kg per day or ate at 10 mg/kg per day for two weeks.
Mice were chosen in accordance with the recommendations of the
Mouse Phenome Database (MPD) so as to cover as much genetic
diversity as possible [15], the density of genotypic information
available in each strain and their suitability with the experimental
design. For these reasons, wild-derived inbred lines were excluded
from the panel.
Our study provides a rich dataset of cardiovascular-related
phenotypes upon b-adrenergic challenge in different genetic
backgrounds. We first focus our analysis on the response of key
measurements including HR, SBP, ventricular and atrial weight
indices, body weight and weight gain, as well as ECG parameters.
We then explore the complete dataset using unsupervised bi-
clustering to elucidate and visualise the patterns of correlations
between strains, treatments, and phenotypes. We compare strain
similarity based on the phenotypes with genotypic relatedness
computed from genomic SNP profiles. Information extracted from
these analyses is discussed in terms of novelty and biological
implications. Finally, we discuss the suitability of using our data to
map underlying genetic loci by association studies.
Results
In this study, hereafter abbreviated CV-PGX (for ‘‘cardio-
vascular pharmaco-genomics’’), we have characterised 23 inbred
mouse strains for 27 cardiovascular and related phenotypes such
as systolic blood pressure (SBP), heart rate (HR), electrocardio-
gram (ECG) parameters and cardiac weight indices, either under
baseline condition (ctr) or in response to chronic administration of
isoproterenol at 1 (iso1)o r1 0( iso10) mg/kg per day or atenolol at
10 mg/kg per day (ate), as described in Materials and Methods
and in Figure 1. Traits are listed in Table 1 and mean values
and standard deviations of ten selected phenotypes across all
strains and drug conditions are presented as bar graphs in
Figure 2 (see Supplement S1 for all traits). One-way Analyses
Of Variance (ANOVA) showed high reproducibility for all
phenotypes measured under ctr or any given treatment. In
particular, variances were significantly smaller within than
between strains, indicating that all phenotypic responses are
highly heritable (typically 0.7,H
2,1; Supplement S1).
Figure 1. Phenotypic monitoring and timing in inbred mice.
Animals were trained on the Visitech BP-2000 tail-cuff apparatus on a
daily basis from days 1 to 5 and 8 to 9. SBP and HR were effectively
recorded on days 10, 11, and 12. Osmotic mini-pumps loaded with the
appropriate drugs were implanted sub-cutaneously on day 3 under
anaesthesia. ECGs were recorded on day 15 under halothane
anaesthesia. Mice were sacrificed by decapitation on day 17.
doi:10.1371/journal.pone.0006610.g001
Table 1. Phenotypes and abbreviations.
condition abbreviation phenotype
in conscious mice HR (TC) heart rate (tail-cuff; beats/min)
SBP systolic blood pressure (tail-cuff; mmHg)
BWS body weight at start (g)
BWE body weight at end (g)
BWG body weight gain (g)
under anaesthesia HR (ECG) heart rate (beats/min)
Pamp amplitude of p wave (mV)
Parea area of p wave (mV*ms)
Pdur duration of p wave (ms)
PR PR interval (ms)
RR RR interval (ms)
Qamp amplitude of Q wave (mV)
QRS QRS interval (ms)
QRSarea area of QRS complex (mV*ms)
QT QT interval (ms)
QTc corrected QT interval (ms)
Ramp amplitude of R wave (mV)
Samp amplitude of S wave (mV)
ST ST interval (ms)
after euthanasia HW heart weight at end (mg)
VW weight of cardiac ventricles (mg)
VWI ventricular weight index (ratio VW/BWE
in mg/g)
VW/BWS ventricular weight index (ratio VW/BWS
in mg/g)
AW weight of cardiac atria (mg)
AWI atrial weight index (ratio AW/BWE in mg/g)
AW/BWS atrial weight index (ratio AW/BWS in mg/g)
VW/AW ratio VW/AW
doi:10.1371/journal.pone.0006610.t001
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We first focused on data recorded in baseline condition. As
some of these traits, in particular SBP and HR, are notoriously
sensitive to slight perturbations of environmental or experimental
conditions, we assessed the consistency of our data with
information available from independent experiments and labora-
tories. To do so, we calculated Pearson’s and Spearman’s
correlations between our mean ctr measurements and values from
multistrain records of the MPD [15] across the common strains.
These comparisons were restricted to MPD projects using inbred
strains and experimental procedures similar with those of the
present study. A subset of five such pair-wise comparisons is
illustrated in Figure 3, while more comprehensive results are
available in Supplement S1.
The most robust phenotypes were those related to body and
heart weight, with Pearson’s correlations r
2.0.5 (p,0.01) in at
least one third of the comparisons (Supplement S1). This strong
conservation is illustrated by the significant correlations of BWE
and VWI with the dataset of Deschepper [16], in which ten
strains were common with the present study (Figure 3). Results
were more divergent for the weight of cardiac atria, as average
AWI of most strains was lower in the CV-PGX study than in
Deschepper’s data (Figure 3). This discordance is most likely
related to the small size of the atria and may be a result of subtle
differences in the dissection process rather than intrinsic strain
variability.
The conservation of baseline HR and SBP strain means across
independent studies was much weaker, as illustrated by the two
examples in Figure 3. Yet, the total numbers of significantly
correlated CV-PGX vs MPD datasets were higher than expected
by chance for both traits (Supplement S1), suggesting that
despite marked susceptibility to the environment, blood pressure
and heart rate are also controlled in part by genetic determinants.
Altogether, these comparisons indicate that ctr measurements are
consistent with data from other studies, further supporting the
validity of our experimental protocol.
Figure 2. Means and standard deviations of ten selected phenotypes in 23 inbred mouse strains. White bars: ctr; blue bars: ate; orange
bars: iso1; red bars: iso10. Strains are ranked by increasing HR (TC) means of ctr mice. See Table 1 for abbreviations.
doi:10.1371/journal.pone.0006610.g002
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with those obtained (i) by tail-cuff in the same animals (Pearson
r
2=0.02, p=0.52; Supplement S1) or (ii) by ECGs in
independent studies (MPD). Considering that tail-cuff experiments
were performed in conscious mice whereas ECGs were recorded
under anaesthesia, these discrepancies may point towards strain-
specific confounding effects of anaesthesia.
Patterns of trait and strain correlations in baseline
condition
Baseline phenotypes were further investigated for patterns of
correlations across strains. To this end we normalised phenotypic
data into z-scores and analysed them by hierarchical bi-clustering
(Supplement S1). In these re-ordered tables (matrices) of z-
scores, phenotypes (columns) were clustered according to the
absolute values of the similarities across all strains while strains
(rows) were clustered according to signed similarities across all
phenotypes.
The vast majority of the ctr phenotypes were only mildly
correlated across strains (correlations r,0.5, Suppl. Figure 5A
in Supplement S1) but as expected, HW, AW and VW
increased with BWE (correlations r.0.7, p,0.05). Interestingly,
these traits also shared good similarity with Pdur (0.4,r,0.7,
p,0.05). In contrast, no significant correlation could be
identified between HR and SBP (r=0.25, p=0.26), between
HR and VWI (r=20.21, p=0.34) or AWI (r=20.12, p=0.59),
and between SBP and AWI (r=0.04,p=0.87)orVWI(r=0.27,
p=0.22). In anaesthetised mice, ECG intervals were only mildly
correlated to HR. Altogether these data suggest that the genetic
components contributing to most baseline phenotypes are largely
independent.
Phenotypes measured under atenolol or isoproterenol
treatment
We next focused on strain responses to chronic b-adrenergic
blockade or activation. For each phenotype p and strain s a signed
significance value
Stps~sign r t,p,s ðÞ ðÞ : {log10pt ,p,s ðÞ ½ 
was attributed to the effect of each treatment t=ate, iso1, iso10 with
respect to the ctr group. We used the Wilcoxon ranksum test, with
test statistics r~r t,p,s ðÞ and associated p-value pt ,p,s ðÞ . Signed
significances are presented in Figure 4 for the same parameters
and strain order as in Figure 2 (graphs for all phenotypes are
available in Supplement S1). Altogether, the amplitudes of
responses to drug treatments were strain-specific and high- or low-
responders could be identified for each trait. Most phenotypes
were affected by (at least the highest dose of) iso with a nominal
significance level of p,0.05 in at least one strain, whereas the
opposite effect of ate was usually milder. Below, we focus on the
results of HR, SBP and cardiac weight indices. Information
regarding the effect of ate and iso on ECG parameters and body
weight are available in Supplement S1.
We note that the significance levels in Figure 4 (and Suppl.
Figure 4 of Supplement S1) have not been corrected for
Figure 3. Conservation of baseline phenotypes across independent studies. Five comparisons of ctr CV-PGX strain means with means of
selected MPD projects are illustrated. The dashed line is the diagonal of identity and the red line is the best fit of (x:y) pairs. Data are presented as
means6SD. See Table 1 for abbreviations. r2: squared coefficient of correlation (Pearson); p: p-value.
doi:10.1371/journal.pone.0006610.g003
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the global context of our analysis, the significance threshold has to
be adjusted. A simple procedure is the well-known Bonferroni
correction, where the nominal significance threshold a=0.05 is
lowered to a’=a/N (N being the number of tests). For example,
for a given phenotype (or strain) one corrects for considering
simultaneously N=23 (N=27) tests, giving a’<0.002. Thus
significance values extending beyond the (green) threshold lines
at63i nFigure 4 clearly hold up against testing all strains or all
phenotypes. Yet, this correction is very stringent and over-
conservative – in particular when correcting for testing all
phenotypes and all strains. Thus we also applied the Benjamini-
Hochberg (BH) step-up procedure [17,18] to correct for multiple
hypotheses testing. This procedure controls the false discovery rate
yielding adequate, yet significantly milder corrections. We report
globally BH-corrected p-values as well as those for any given
phenotype or any given strain (correcting for all 23 strains or all 27
phenotypes, respectively) in Supplement S1.
Heart rate in conscious mice
The most robust effect of the b-adrenergic drugs was the
pronounced strain-specific positive cardiac chronotropy induced
by both concentrations of iso in all 23 strains (Figures 2 and 4).
Under iso10 stimulation, mean HR was increased between 61643
beats/min in strain SWR/J and 279633 beats/min in strain
BTBRT
+tf/J. The lower concentration of iso induced a similar or
even slightly higher (i.e. see strains A/J, AKR/J, C3H/HeJ and
SJL/J) acceleration in sixteen strains, while for the seven other
lines HR was significantly higher under iso10 than iso1 (Figures 2
and 4). Conversely, the opposite properties of ate on HR were
significant in all strains except both Balb/c lines, reaching a
maximal reduction of 141643 beats/min in strain SWR/J.
Figure 4. Intra-strain significance of drug treatments. Data are presented for the phenotypes selected in Figure 2. Intra-strain p-values of
phenotypic data recorded in treated vs untreated groups (Wilcoxon ranksum statistics) are presented as bar graphs on a -log10 scale. The threshold
of significance is indicated by red lines (p=0.05) and -log p-values are signed according to the directionality of the effect induced by the drugs. When
significant, p-values for testing responses under iso10 vs iso1 are indicated by coloured stars (i.e. *: p,0.05; **: p,0.01; ***: p,0.001; red star:
phenotypic mean under iso10. phenotypic mean under iso1; blue star: phenotypic mean under iso10,phenotypic mean under iso1). Blue bars: ate
vs ctr; orange bars: iso1 vs ctr; red bars: iso10 vs ctr. P-values smaller than 0.001 (bars extending beyond the green lines or ***) hold up against
Bonferroni correction for multiple testing of either all strains for a given phenotype or all phenotypes for a given strain. Strains are ranked as in
Figure 2. See Table 1 for abbreviations.
doi:10.1371/journal.pone.0006610.g004
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to b-stimulation had lower baseline HR, while stronger
responders to b-blockade had higher ctr HR. In other words in
most strains baseline values could be used to predict the
magnitude of rate changes in response to pharmacological
treatment. These data may reflect the existence of electrical and/
or mechanical limits to the pacing capacity of the atrial sinus
node. Reaching the upper limit of cardiac pacing would explain
the relatively weak iso-mediated positive chronotropy in strains
SJL/J and SWR/J, whose pulse was initially high. Accordingly,
strain upper limits were attained in at least sixteen lines exposed
to iso (i.e. those in which pulse recorded under iso1 was higher or
similar as under iso10), ranging from 69764 5b e a t s / m i ni ns t r a i n
Balb/cByJ to 87764 5b e a t s / m i ni ns t r a i nI / L n J .I ti sm o r e
difficult to draw conclusions regarding the lower limit of pacing
automaticity, since a single dose of b-blocker was used. Yet, HR
mean values measured in conscious ate-treated mice were never
lower than the baseline pulse values of strain Balb/cByJ (i.e.
442635 beats/min).
r
2 values of Pearson’s correlations between pulse rate recorded
in resting state or under drug treatment were 0.74 for ate vs ctr
(p=1.4610
27), 0.54 for iso1 vs ctr (p=7.3610
25), and 0.22 for
iso10 vs ctr (p=2.5610
23; Suppl. Figure 3 of Supplement S1).
This information is consistent with iso10 producing the strongest
perturbations on HR and indicates that the patterns of drug- and
dose-dependent HR responses are strain-specific. Similarly, when
assessing the impact of the treatments on the correlations with the
datasets of the MPD (Supplement S1), Pearson’s r
2 values
decreased when comparing pulse of drug-treated animals instead
of our ctr with that of Hampton1’s records [19]. When considering
the other MPD projects, correlations were the highest in (CV-
PGXate:Svenson), (CV-PGXiso10:Gavras), and (CV-PGXiso10:Jax-
west1HR) pairs (Supplement S1), probably reflecting differences
in stress levels across projects.
Systolic blood pressure.. Perturbations of the b-adrenergic
system resulted in rather subtle effects on blood pressure. Ate
tended to slightly decrease SBP, but the effect was below
significance in all strains except C57BL/6J (Figure 4). Iso1 also
reduced SBP, on average by 10 mmHg, probably as a result of
vasodilation. This decrease reached significance in five strains
(C3H/HeJ, C57BL/6J, FVB/NJ, PL/J, and SJL/J). As for iso10,i t
tended to slightly increase SBP in the majority of the strains,
perhaps as a consequence of increased cardiac inotropy, but the
trend was significant in a single line (i.e. Balb/cByJ). Even though
differences between iso-treated and ctr mice were globally minor,
the opposite action of iso1 and iso10 on SBP was significant in
fourteen strains (Figure 4). Modest hemodynamic changes in
response to iso are consistent with previous data obtained in rats
[20] and mice [13], confirming that cardiac hypertrophy induced
by iso is essentially independent of SBP.
Figure 5. Patterns of phenotype and strain correlations under drug treatment. For each phenotype (rows) and combination (columns) of a
strain and a treatment (ate, iso1, iso10) the significance (signed -log10 value of Wilcoxon ranksum test, as used in Figure 4) of the phenotypic
response with respect to the ctr group is shown using a colour code. Rows and columns are clustered according to pattern similarity. The branches of
the dendrograms illustrating the clusters are plotted with the same colour as long as the average linkage distance is less than 20% of the maximal
distance. AC: ate vs ctr; I1C: iso1 vs ctr; I10C: iso10 vs ctr. See Table 1 for abbreviations. HR std: standard deviation of HR (TC) strain means; SBP std:
standard deviation of SBP strain means.
doi:10.1371/journal.pone.0006610.g005
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activation of the b-adrenergic system is a classical trigger of left
ventricular hypertrophy [12,21]. In our study, iso induced strain-,
dose- and compartment-specific perturbations of cardiac mass
(Figures 2, 4 and Supplement S1). Under infusion of iso10, the
relative increase of VWI reached significance (p,0.05) in nineteen
strains, ranging from 1.7% in C57BL/6J mice to 33% in 129S1/
SvImJ (i.e. C57BL6/J: 4.360.03 mg/g in iso10 vs 4.260.04 mg/g
in ctr; 129S1/SvImJ: 6.060.26 mg/g in iso10 vs 4.960.05 mg/g in
ctr). By comparison, only three lines differed from the controls in the
iso1-treated group, reaching a maximal relative increase of 11% in
strain A/J (Figure 4). These three strains were all characterised by
a positive dose-response to iso. In contrast to the above, the
resistance of strains AKR/J, C57BL/6J, and PL/J to b-stimulation
was characterised by similar indexed and non-indexed ventricular
weight in treated and untreated mice (Figures 2 and 4, and data
not shown), whereas the small variation of VWI in C58/J mice was
the consequence of parallel increases of VW and BW.
Cardiac atria responded to chronic b-stimulation with the same
directionality as the ventricles but exhibited more pronounced
sensitivities to iso (Figures 2 and 4): AWI was increased by iso1 in
fifteen strains, including those with poor responding ventricles, and
by iso10 in all lines (p,0.05). The magnitude of atrial hypertrophy
was larger under iso10, extending from a relative increase of AWI
of 22% in strain Balb/cByJ to 57% in CBA/J.
Consistent with the fact that ate was administered to healthy
mice, b-blockade only modestly affected cardiac weight and
indices in the majority of the strains. Three of the four lines
resistant to iso responded by a significant reduction of VWI under
ate (i.e. AKR/J: 26.4%; C58/J: 27.8%; and C57BL/6J: 25.6%,
p,0.05), but a concomitant reduction of VW was significant only
in C57BL/6J mice (data not shown). Similarly, the overall impact
of ate on cardiac atria was negligible except in strain NOD/ShiLtJ
that exhibited a relative increase of AW and AWI of 21% when
compared to controls.
Of note, the weak iso-dependent increase of VWI in strain
C57BL/6J is consistent with the data of Faulx et al. who
investigated cardiovascular changes in 12–15 week-old A/J and
C57BL/6J males challenged with five consecutive daily injections
of 100 mg/kg iso [22]. In these conditions, the heart weight index
(HWI) increased by 2.7% in strain C57BL/6J and by 23% in
strain A/J. In contrast, HWI in 8-wk old C57BL/6J males infused
with 40 mg/kg iso for seven days increased from 5.0 in ctr to
6.0 mg/g (i.e. a relative increase of 22%) in treated animals [23].
These apparent inconsistencies may relate to the fast biotransfor-
mation of iso by liver enzymes [9]. In the latter example, the dose
of continuously-administered iso was indeed four-fold higher than
the CV-PGX iso10 concentration. While the 100 mg/kg used by
Faulx et al. might seem even higher, one should keep in mind that
in this case iso was administered in single daily shots. Thus, the
Figure 6. Patterns of phenotype and strain correlations under drug treatment. For each strain (rows) and combination (columns) of a
phenotype and a treatment (ate, iso1, iso10) the significance (signed -log10 value of Wilcoxon ranksum test, as used in Figure 4) of the phenotypic
response with respect to the ctr group is shown using a colour code. Rows and columns are clustered according to pattern similarity. The branches of
the dendrograms illustrating the clusters are plotted with the same colour as long as the average linkage distance is less than 50% of the maximal
distance. AC: ate vs ctr; I1C: iso1 vs ctr; I10C: iso10 vs ctr. See Table 1 for abbreviations. HR std: standard deviation of HR (TC) strain means; SBP std:
standard deviation of SBP strain means.
doi:10.1371/journal.pone.0006610.g006
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delivered in a sustained fashion as most of it would have been
rapidly metabolised and eliminated.
Correlations and clustering of phenotypes in the presence
of b-adrenergic drugs. Each drug treatment was assessed for
its impact on the patterns of correlations across mean trait values
or strains (see Suppl. Figures 5–7 in Supplement S1). The
high correlations between HW, AW, VW and BWE were globally
maintained also upon perturbations of the b-adrenergic system but
were slightly reduced under iso10 as compared to ctr mice (i.e.
Figure 7. Comparison of strain relatedness based on phenotypes or genotypes. Along the main diagonal, five clustered correlation
matrices C
k ðÞ
ss0 (where k=ctr, ate, iso1, iso10, or G) across all phenoypes or SNPs (k=G) are shown. Similar strains are placed close to each other and
their order is indicated by the coloured circles and dendrograms displayed on the right as determined by standard hierarchical clustering. Above
these five matrices ten composite matrices are shown whose lower left part consists of the correlation matrix shown on the main diagonal to the left,
while their upper right contains the correlations from the dataset indicated on top, using the same order of strains (i.e. the rows of all adjacent
correlation matrices correspond to a fixed strain). The degrees of correlations are indicated by a colour code. In the scatter plots below the diagonal,
each pair of strains (s,s’) is represented by a dot whose coordinates are given by the correlationsCk
ss0 and Ck0
ss0 where k and k’ are indicated on the left
and top, respectively. The correlation r2 between these dots is indicated and a red line shows the best linear fit. Blue arrow: C3H/HeJ vs CBA/J, red
arrow: 129S1/SvImJ vs LP/J, green arrow: C57BL76J vs C57BLKS/J.
doi:10.1371/journal.pone.0006610.g007
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Supplement S1). High similarity of HW and VW with Pdur
was still detected under b-stimulation (i.e. 0.5,r,0.8) but it was
significantly reduced under ate (r=0.19, p=0.38). Again and
irrespective of the drug condition, no significant correlation could
be identified between HR and SBP, between HR and VWI or
AWI, and between SBP and AWI or VWI.
Structure of the response to b-adrenergic drugs
In the previous paragraphs, we focused on the differential
behaviour of a selection of traits across strains and treatments,
considering one trait and/or one drug condition at a time. Yet,
such serial screening is not well suited to fully exploit the rather
large set of phenotypic data we generated (i.e. 27 phenotypes
measured in 23 strains and under 4 treatment conditions). In order
to explore the relationships between the various parameters in a
more comprehensive manner and to provide a more global picture
on the structure of these data, we performed unsupervised bi-
clustering analyses. Specifically, we transformed the three
dimensional table Stps of the signed p-values attributed to the
effect of each treatment (t=ate, iso1, iso10) with respect to the ctr
group into two two-dimensional tables (matrices). The first matrix
Spi (Figure 5) has one row for each phenotype p, while each
column i refers to a combination (t,s) of a treatment t in strain s.
Conversely, the second matrix Ssj (Figure 6) has one row for each
strain s, while each column j refers to a combination (t,p)o fa
treatment under which the phenotype p was observed (we chose
not to consider a matrix that has one row for each treatment).
Hierarchical bi-clustering was applied to determine clusters in
these matrices (see Materials and Methods for details). Strains
were clustered according to (signed) values of similarity (i.e.
Pearson correlations between significance profiles across all
phenotypes). In contrast, we used absolute correlations as
similarity measure between phenotypes (such that inversely related
observables, like HR and ECG intervals are clustered together).
The reordered matrices together with the similarity dendrograms
are shown in colour codes, providing a convenient, unbiased and
condensed means to compare subsets (clusters) of related
phenotypes or strains based on their response to b-adrenergic
drugs.
In Figure 5, strain responses to pharmacological challenge (i.e.
‘‘treated strains’’) clustered mainly according to the type of drug,
as the first branching in the tree clearly discriminates ate- from iso-
treated lines (with the exception of strain Balb/cByJ under ate).
This segregation reflects the opposite response of HR to the two
antagonist drugs, indicating that HR reaction to treatments was
the most discriminative phenotype of the whole dataset (according
to principle component analysis, data not shown). Sub-clustering
in iso-mediated responses was essentially driven by the strain-
specific and dose-dependent responses of cardiac ventricles and
atria to b-stimulation. This resulted in an almost perfect
segregation between the iso1- and iso10-treated groups of strains.
Five strains were poor responders to iso1 at the level of cardiac
atria (when compared to controls) and segregated in three separate
clusters (i.e. strains KK/HlJ, DBA/2J, Balb/cJ, NZB/BlNJ, and
Balb/cByJ). Of all strains exhibiting increased AW and AWI
under iso, a subset of twelve lines exhibited modest changes of
HW, VW and VWI (i.e. see green cluster of treated strains in
Figure 5). This effect was present under iso1 in ten strains (i.e.
strains NOD/ShiLtJ, C57BLKS/J, SM/J, C3H/HeJ, LP/J,
SWR/J, FVB/NJ, CBA/J, C58/J, and PL/J) and under both
concentrations of iso in lines AKR/J and C57BL/6J. The main
trends in the remaining strains were essentially (but not exclusively)
observed under iso10. They were dominated by concomitant
increases of AW, AWI, HW, VW, and VWI. These strong
responding strains clustered into two distinct subsets, depending
on the effect of sustained b-stimulation on BW and BWG. Thus,
both values remained unchanged in six lines (i.e. PL/J, KK/HlJ,
FVB/NJ, DBA/2J, Balb/cByJ, and A/J), while they tended to
increase in the majority of the fourteen others (i.e. see purple
cluster of treated strains in Figure 5). While strains of the green
sub-cluster tended to exhibit reduced blood pressure under
treatment, this trait was either stable or slightly increased in the
yellow and purple groups.
Looking at the categorisation under b-blockade, we first note
that both Balb/c strains were relatively insensitive to ate,i n
particular for HR. As such, they did not co-segregate with any of
the other lines. The next most informative sub-category correlates
best with HR patterns of the ECG data, mirroring differential
pulse responses under anaesthesia.
From the same figure, it is also possible to address the
segregation of phenotypic modifications across all treatments.
More specifically, the first two clusters (i.e. red and green clusters of
phenotypic changes, Figure 5) include responses of traits related
to cardiac weight and indices (correlations across trait responses:
0.5,|r|,1, Suppl. Figure 8A, Supplement S1). The
structure of these clusters was essentially determined by the
differential (and dose-dependent) effects of iso on cardiac ventricles
and atria. These responses are in relatively close proximity with
those of HR (absolute correlations: 0.5,|r|,0.9), PR (absolute
correlations: 0.6,|r|,0.8), BWE (correlations: 0.4,r,0.8) and
BWG (correlations: 0.4,r,0.8), whereas the patterns of SBP
variations are more discordant (absolute correlations: |r|,0.4).
Interestingly, despite the effect of anaesthesia on ECG parameters,
significance scores for the two measurements of HR responses are
highly correlated across all treated strains (r=0.79, p=3 610
27,
Suppl. Figure 8A, Supplement S1), even though the
respective baseline values were only poorly correlated. This is
reflected by HR and HR (ECG) appearing co-clustered, while the
patterns of PR intervals modifications are slightly more distinct
(correlation with HR: r=20.67, p=7 610
25). Control phenotypes
such as body weight before treatment (BWS) and SBP standard
deviation (SBP std) that did not notably vary across strains and
drug conditions did not cluster with the other variables. Apart
from Pamp, amplitudes and areas of ECG waves, which were
poorly affected by the drugs, are also relatively distant from the
other traits.
Figure 6 summarises the clustering of inbred strains as
determined by their responses to ate and iso. As expected, strains
were all positively correlated (i.e. correlations: 0.4,r,1, Suppl.
Figure 9A, Supplement S1), indicating that they usually
differed only in the relative amplitude but not the directionality
of the responses. NZB/BlNJ mice were on average the least
affected by the treatments and as such the most distant from the
others. Three sub-groups seem to emerge from this analysis. The
first one comprises fourteen strains organised in two clusters and
two separate lines (i.e. red cluster: strains CBA/J, FVB/NJ, SM/J,
C3H/HeOuJ, C3H/HeJ, C57BLKS/J, NOD/ShiLtJ, SWR/J,
and C58/J; blue cluster: strains 129S1/SvImJ, I/LnJ, and
BTBRT
+tf/J; as well as strains LP/J and SJL/J, Figure 6;
correlations: 0.7,r,1, Suppl. Figure 9A, Supplement S1)
while the second category includes five strains (i.e. A/J, DBA/2J,
KK/HlJ, BALB/cByJ, and BALB/cJ; correlations: 0.6,r,0.9).
Three additional strains (i.e. AKR/J, PL/J and C57BL/6J) are in
mild proximity with the first sub-group (i.e. correlations:
0.6,r,0.9) and more distant from the second one (i.e.
correlations: 0.4,r,0.8). Trends specific to the first sub-group
are marked increases of (i) HR (ECG) under iso, (ii) AW, AWI,
Mice and b-Adrenergic Drugs
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second cluster is characterised by very mild changes of (i) HR
under anaesthesia, (ii) AW and AWI under iso1 and (iii) BWG
under iso10, whereas HW, VW, and VWI are significantly
increased by iso10. The three strains standing between these two
groups correlate with very mild variations of VW, HW, and VWI
under both concentrations of iso as well as decreased SBP under
iso1. It is tempting to speculate that these phenotypic patterns
segregate due to specific genetic determinants but further analyses
will be required to establish our observations and link them to
genetic variation.
On the other axis of Figure 6, phenotype treatment
combinations exhibit no clear clustering hierarchy (except for
small groups of trivially related phenotypes). Rather weakly
affected traits in response to b-adrenergic perturbations gradually
agglomerate towards the right, the more strongly affected traits
appearing on the left.
Strain relatedness based on phenotypic or genotypic
data
Of the 23 strains characterised above, 21 have been genotyped
at a genome-wide density of over 1009000 SNPs [24]. To compare
strain proximity based either on the phenotypes observed in each
of the four experimental conditions (ctr, ate, iso1 and iso10; Suppl.
Figures 5 and 7 in Supplement S1) or on these genotypes (G;
Suppl. Figure 10 in Supplement S1), we computed the five
corresponding correlations matrices C
k ðÞ
ss0 (where k=ctr, ate, iso1,
iso10,o rG, see Materials and Methods for details). In
Figure 7, these (symmetric) matrices are drawn along the main
diagonal of the figure (i.e. from top left to bottom right) with similar
strains placed close to each other (i.e. the highest inter-strain
correlations tend to appear close to the diagonal of each matrix).
Strain order was determined by standard hierarchical clustering
and is indicated by the circles and dendrograms displayed on the
right of the figure. Specifically, the order based on phenotypic (ctr)
relatedness is symbolised by shades inside the circles graded from
black to white, whereas the order based on genetic proximity is
represented by shades graded from green to white (i.e. each circle
represents a single strain and strains with similar shades tend to be
closely related). Dendrograms associated to trait-based relatedness
are identical to those of Suppl. Figures 5 and 7 (Supplement
S1), with the exception that strains Balb/cJ and C3H/HeOuJ, for
which genetic information was missing [24], were not taken into
account. Above these five matrices we show ten composite
matrices. In each of the latter, the lower left part is identical to
the correlation matrix shown on the main diagonal on the left,
while the upper right contains the correlations within the datasets
indicated on top (while keeping the same strain order as in the
lower left part). In other words, the matrices in the top row of the
figure allow for the successive comparison of the strain proximity
as determined by ctr phenotypes with those obtained from traits
recorded under ate, iso1 and iso10 or from the genotypes.
Accordingly, the second row allows for comparison across
treatments or genotypes using the strain order as determined by
ate phenotypes, and so on. Below the main diagonal we show
scatter plots, where for each pair of strains (s,s’) we draw a dot
whose coordinates are given by the correlations C
k ðÞ
ss0 and C
k0 ðÞ
ss0
where k and k’ are indicated on the left and top, respectively. The
correlation r
2 between these dots is indicated and a red line shows
the best linear fit of the data.
Pair-wise comparisons indicate that the patterns of strain
relatedness based on any of the four sets of phenotypic data are
positively correlated. The closest profiles are those obtained from
traits measured in ctr and ate mice (i.e. correlation r
2=0.63,
p=7 610
27), while those resulting from the phenotypes measured
in ctr and iso10 or ate and iso10 are significantly more divergent (i.e.
r
2=0.36, p=0.001 and r
2=0.36, p=0.001, respectively,
Figure 7). These differences reflect the strain-specificity of the
trait modifications induced by the b-adrenergic drugs, in particular
iso10.
Nominal values of inter-strain correlations based on whole-
genome genetic profiles are detailed in Suppl. Figure 10
(Supplement S1). In this analysis, the vast majority of the
correlations are below 0.2. Four non-overlapping clusters of strains
are characterised by correlations above this value, the closest pairs
being 129S1/SvImJ vs LP/J, C3H/HeJ vs CBA/J, and C57BL/6J
vs C57BLKS/J (i.e. all with correlations r.0.4). This hierarchy
agrees well with the known ancestry of laboratory mouse strains
[25,26]. Irrespective of the drug condition, we observe little
concordance when comparing overall strain phylogeny based on
phenotypes with relatedness computed from the genomic SNP-
profiles (Figure 7). Yet, it is interesting to note that the three
genetically closest pairs of strains tend to segregate in the same or
adjacent trait-based clusters (see arrows in Figure 7 and related
clusters in Suppl. Figure 7 of Supplement S1). This is true for
strains 129S1/SvImJ and LP/J in all conditions and for strains
CBA/J and C3H/HeJ as well as C57BL/6J and C57BLKS/J in
ctr, iso1, and iso10 conditions. Conversely, we have already
highlighted divergence between strains C57BL/6J and A/J or
C57BL/6J and 129S1/SvImJ for traits such as VWI under b-
stimulation. Accordingly, when considering all phenotypes, trait-
based relatedness is consistently relatively low between these latter
pairs of strains (Suppl. Figure 7 in Supplement S1).
Nevertheless, globally the correlation between relatedness based
on our cardiovascular phenotypes and whole-genome SNP profiles
is low. This suggests that these phenotypes are likely to be
governed by smaller, local differences in the genomes of the
various strains.
Discussion
Inter-individual differences in response to medication are well-
established clinical issues, the study of which is a large field of
research in itself. Yet, pharmacogenetic studies in humans are
hampered by several important concerns such as compliance
issues, environmental confounders and limitations to non-invasive
measurements. In this context laboratory mice, which have
already played a key role for dissecting the genetic basis of disease
susceptibility and providing key support for many current concepts
of disease pathogenesis and treatment strategies, are also likely to
become instrumental for complementing and furthering human
pharmacogenetics [27]. Indeed, several recent studies already
addressed the genetic basis of strain-specific susceptibility to
carcinogens [28,29] and analgesics [30,31] or the metabolism of
warfarin, testosterone and irinotecan [32,33] in inbred mice.
Here we undertook a similar approach focusing on the
cardiovascular system. Our large survey assessed the suitability
of using a large panel of inbred mouse strains to investigate
physiological responses to b-adrenergic treatments. To the best of
our knowledge, it provides the first large-scale standardised
characterisation of heart rate, systolic blood pressure, ECG and
cardiac weight indices in response to sustained infusion of atenolol
and isoproterenol in such a panel.
The robustness of our experimental standards is supported by
several essential validation steps: first, mean strain values measured
in ctr condition correlated well with independent datasets of the
Mouse Phenome Database. In agreement with the notion that
morphological parameters are highly heritable and least affected
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most consistent with independent studies. Even though conserva-
tion across independent datasets was much reduced for SBP and
HR, the number of significant between-projects correlations was
higher than expected by chance for both traits. As discussed by
others [16,34,35], this confirms that despite marked susceptibility
to environmental factors, a significant portion of HR and SBP
variance observed in inbred mouse strains is genetically deter-
mined. Second, phenotypic variances were generally smaller
within than between strains, indicative of elevated trait heritabil-
ities (i.e. typically H
2.0.7). H
2 values were indeed significantly
higher than in human populations, in particular for SBP, HR and
ECG intervals (see for instance [36], [37] and [38]), where H
2
estimates typically vary around 0.6 in twin studies and around 0.25
in nuclear families. This further emphasises the potential of using
our mouse model instead of traditional human cohorts for
downstream genome-wide association scans. Third and regardless
of the treatment conditions, strain means for all phenotypes had
uni-modal distributions, consistent with the idea that they are
complex traits under the control of multiple genetic loci.
We found that cardiovascular responses to drug exposure were
trait-, drug-, and dose-specific. In order to obtain a comprehensive
and unbiased overview of the structure of the phenotypic data with
respect to the relationships across strains, treatments, and
phenotypes, we performed a comprehensive comparative investi-
gation. Our unsupervised bi-clustering analyses facilitated pro-
cessing the large phenotypic data in order to extract key
information regarding strain proximity and drug-dependent
phenotypic perturbations. For instance our clustered matrices of
significance score made immediately apparent that phenotypic
changes were usually more significant under b-stimulation than b-
blockade (consistent with iso and ate being administered to healthy
animals housed in a reduced stress environment). When
considering all experimental conditions, HR was the most, and
SBP and QTc the least affected phenotypes in response to both
pharmacological compounds. Strain responses of phenotypes
related to body and heart weight (i.e. HW, AW, AWI, VW,
VWI, BWE, BWG) were well correlated with drug-induced
changes of heart rate and ECG intervals (in particular PR, Pdur,
QT and ST), but not with the responses of systolic blood pressure
and ECG wave amplitudes or areas. Trait-specific patterns of
sensitivity to iso ranged from maximal response under treatment
with iso1 for HR to negligible effects under either concentrations of
iso for SBP. We detected compartmental and strain-specific
cardiac sensitivity to iso, with atria responding at lower
concentrations than ventricles in the majority of the strains. At
this stage, the biological mechanisms underlying differential
sensitivities to chronic b-stimulation are not known but might
reflect distinct and strain-specific distributions of atrial and
ventricular b-adrenergic receptors and/or differential downstream
signalling pathways. Altogether, these data suggest that responses
to b-adrenergic drugs by themselves are determined by complex
genetic architectures. Beyond the specific context of the present
study, it is worth mentioning that the unsupervised bi-clustering
analyses we employed in this study could also be useful for
dissecting other large datasets of complex phenotypic traits, which
are likely to become more and more frequent.
Due to their broad use to generate transgenic or knock-out
models, the lines C57BL/6J and 129S1/SvImJ are of particular
interest. Our comprehensive analyses as well as other reports
[16,34,35] have clearly highlighted their differential behaviours for
baseline phenotypes such as SBP, atrial and ventricular size, heart
rate, heart rate variability and cardiac metabolism. Recently,
Barrick et al. further emphasised on the specificity of 129S1/SvImJ
and C57BL/6J responses to prolonged trans-aortic constriction
(TAC), another model of left ventricular hypertrophy associated
with increased hemodynamic load and sustained b-adrenergic
stimulation [39]. Upon aortic banding, C57BL/6J mice had an
earlier onset and more pronounced impairment in contractile
function, with corresponding left and right ventricular dilatation,
fibrosis, change in expression of hypertrophy markers, and
increased liver weights at five weeks post-constriction. In contrast,
129S1/SvImJ mice had delayed transition to decompensated heart
failure, with relatively mild alterations in histology and markers of
hypertrophy at five weeks post-TAC and preserved systolic
function until eight weeks post-TAC, suggesting that 129S1/
SvImJ genetic modifiers might protect against the earlier and more
severe pathological changes seen in C57BL/6J mice [39]. In
contrast, in our study, iso10-mediated increase of VWI was marked
in strain 129S1/SvImJ while C57BL/6J mice were significantly
more resistant. This indicates that different signalling pathways
may lead to cardiac hypertrophy, depending on the type of
upstream trigger (i.e. pressure overload vs sustained b-adrenergic
activation). These observations put an additional emphasis on the
need for detailed characterising of these and other strains, both in
terms of baseline cardiovascular phenotypes and in response to
pressure overload or b-adrenergic challenge.
Future work will aim at associating the rich phenotypic data of
this study with genetic markers. Indeed the vast majority of the
strains of our CV-PGX panel has been extensively genotyped [24].
Early studies already suggested that the genome of laboratory mice
is a mosaic of regions of distinct but limited sub-specific origins
[40]. More recent resequencing efforts have refined this picture by
cataloguing over 8 million SNP alleles across 16 inbred strains [41]
and genetic maps of similar densities were further imputed in 49
strains [42]. These invaluable resources allow for inferring the
ancestry of most of the genome with good confidence and provide
mapping resolution usually higher than in other model organisms.
Thus, it is now becoming feasible to map trait variation in inbred
mouse strains by testing association to loci of inferred ancestry
[24,43,44]. Here we already used genomic SNP profiles to show
that overall genetic similarity of the strains exhibits little
concordance with their phenotypic relatedness in terms of the
collection of cardio-vascular traits we measured. This indicates
that cardiovascular phenotypes are unlikely to segregate according
to global phylogeny, but rather be governed by smaller, local
differences in the genomes of the various strains. Thus, given the
significant heritability of many of these traits, we are confident that
association studies using our phenotypic resource have good
chances to reveal new candidate loci related to differential
cardiovascular responses under treatments.
Materials and Methods
Ethics Statement
All animal procedures have been approved by the ‘‘Service
ve ´te ´rinaire cantonal vaudois’’ (authorisation nu 1649) and were
performed in accordance with the National Institutes of Health
(NIH) guidelines for the care and use of laboratory animals.
Mice
Inbred mouse strains were selected from the priority strains list
of the Mouse Phenome Database (MPD: http://www.jax.org/
phenome [15]), based on their genealogy and the density of SNPs
characterised in each strain. Mice were purchased in two to six lots
per strain, either from Charles River, France (strains Balb/cByJ,
C3H/HeOuJ, CBA/J, and DBA/2J) or from the Jackson
Laboratory at Bar Harbor, Maine, USA (strains 129S1/SvImJ,
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+tf/J, C3H/HeJ, C57BL6/J,
C57BLKS/J, C58/J, FVB/NJ, I/LnJ, KK/HlJ, LP/J, NOD/
ShiLtJ, NZB/BlNJ, PL/J, SJL/J, SM/J, and SWR/J). Only males,
aged ten to twelve weeks on average, were included in the
experimental protocol. Mice were housed at our local animal
research facility under conditions of 14 hours light, 10 hours
darkness, ambient temperature of 25uC, and relative humidity of
30–60%.
Pharmacological agents and treatments
Ate and iso (Sigma-Aldrich) were administered to mice
chronically for two weeks (Figure 1). Osmotic mini-pumps (Alzet,
model 2002, Charles River Laboratories) were implanted sub-
cutaneously under anaesthesia and set to deliver ate at 10 mg/kg
per day and iso at 1 (iso1) and 10 (iso10) mg/kg per day. Based on
the results of a pilot comparison of four C57BL/6J mice implanted
with minipumps loaded with 0.9% NaCl vs six non-implanted
isogenic animals, ctr mice were not implanted with minipumps.
Phenotypic characterisation
A general outline of the phenotyping process is presented in
Figure 1. In brief, heart rate (HR) and systolic blood pressure
(SBP) were monitored in conscious animals by the tail-cuff (TC)
method, using a Visitech BP-2000 blood pressure analysis system.
All animals were trained for one week prior to recording effective
values on days 10, 11, and 12 (Figure 1) and all measurements
were taken at a similar time of the day (2–5 pm). Electrocardio-
grams (ECG) were recorded in halothane-anaesthetised mice using
the IOX 1.7.0 and ECG-Auto 1.5.7 softwares (EMKA Technol-
ogies). On day 16 or 17, mice were weighted and sacrificed by
decapitation. Hearts were rapidly excised from the animals, rinsed
in ice-cold phosphate buffered saline (PBS) solution, and blotted
dry. Cardiac atria and ventricles were dissected and weighted
separately. Cardiac tissues were frozen in liquid nitrogen and
stored at 270uC. Phenotypes recorded in the present project are
listed in Table 1. Individual phenotypes were assessed in multiple
series of independent experiments. In each strain, an average of
ten individuals per experimental condition (ctr, ate, iso1 and iso10)
were monitored across all phenotypes.
Data management and statistics
Heritability. The heritability H
2 of each phenotype was
calculated separately for each treatment over all strains. It is
defined as:
H2~
Var G ðÞ
Var G ðÞ zVar E ðÞ
where Var(G) is the genetic (i.e. the inter-strain) variance, and
Var(E) is the environmental (i.e. the intra-strain) variance of the
considered phenotype.
Strain and phenotype clustering. Bi-Clustering was
performed using the MatlabH standard clustering routine.
Similarity between phenotype p and p’ was computed as Cpp0~
P
i jSpiSp0ij
. P
i Spi
   2P
i Sp0i
   2 hi 1=2
. Similarity between strains s
and s’ was computed as Css0~
P
j SsjSs0j
. P
j Ssj
   2P
j Ss0j
   2 hi 1=2
.
See main text for the definitions of Spi and Ssj. Note that both
expressions are invariant under an inverse transformation of any
phenotype.
Phenotypic versus genotypic relatedness. We use Pearson
correlations C
k ðÞ
ss0 ~
P
j z
k ðÞ
sj :z
k ðÞ
s0j both for phenotypic (k=ctr, ate,
iso1, iso10) and genotypic (k=G) similarity. For the latter we first
normalised the genotype of each SNP by taking the z-score across
all strains. Here z
k ðÞ
sj refers to the z-scores (the deviation from the
mean value in units of standard deviation) for phenotypic (j runs
across all phenotypes) or genotypic (j runs across all SNPs) profiles,
respectively.
Supporting Information
Supplement S1 Supplementary Results.
Found at: doi:10.1371/journal.pone.0006610.s001 (1.57 MB
PDF)
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